Ex-Lilly CEO Josh Bilenker & Ex-Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences
Two powerhouse executives have joined forces to form a brand new cancer Biotech company. Josh Bilenker, M.D., and…
Browsing Tag
Novartis International AG is one of the largest pharmaceutical companies in the world. The Swiss multinational pharmaceutical company based in Basel, Switzerland and focuses on providing solutions to address the evolving needs of patients worldwide.
Novartis is reimagining medicine. Utilizing innovative science and technology to address some of society’s most challenging healthcare issues, Novartis is focused on improving and extending people’s lives. They discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. The company is comprised of two divisions – Innovative Medicines and Sandoz – both supported by functional organizations with global scale.
The Innovative Medicines Division is made up of two business units – Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology. This division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.